Showing results (191-200 of 559) with videos related to
Sort By:
Pageof 56
American Heart Journal|September 21, 2015
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trialBram J Geller, Robert P Giugliano, Eugene Braunwald, et al.Circulation|September 5, 2002
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarctionScott D Solomon, Martin St John Sutton, Gervasio A Lamas, et al.Journal of the American College of Cardiology|May 24, 2008
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysisElliott M Antman, Stephen D Wiviott, Sabina A Murphy, et al.Journal of the American College of Cardiology|March 20, 2010
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trialDavid A Morrow, Benjamin M Scirica, Marc S Sabatine, et al.Lancet (London, England)|August 31, 2010
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysisJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.Heart (British Cardiac Society)|March 1, 2012
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromesRagnhild Røysland, Marc P Bonaca, Torbjørn Omland, et al.Circulation|December 20, 2011
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary diseaseMarc S Sabatine, David A Morrow, James A de Lemos, et al.Journal of the American College of Cardiology|January 5, 2005
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudyHisham Dokainish, Manu Pillai, Sabina A Murphy, et al.Journal of the American College of Cardiology|September 11, 2004
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, Kasi Chekuri, et al.Circulation|September 3, 2015
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-ITErin A Bohula, Robert P Giugliano, Christopher P Cannon, et al.Pageof 56